Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CEO INTERVIEW: RAPHAEL MANNINO - BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI).


(WAC609) RAPHAEL MANNINO - BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI BDSI Brooks Divinity School, Inc (Denver, CO) ). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Drug Delivery. Published date 11/24/03. Tickers featured: BDSI. Complete text approximately 3000 words. Document # WAC609.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com.

***
COPYRIGHT 2003 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Nov 24, 2003
Words:91
Previous Article:CEO INTERVIEW: ELAINE HERON - LABCYTE INC.
Next Article:CEO INTERVIEW: CLINTON SEVERSON - ABAXIS INC (ABAX).



Related Articles
BIORAL DELIVERY IMPROVES EFFICACY/REDUCES ASPIRIN SIDE EFFECTS.
BioDelivery announces licensing of its topical BioNasal amphotericin B for chronic sinusitis.
CEO INTERVIEW: FRANCIS O'DONNELL - BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI).
BREAKTHROUGH FOR CANCER PAIN.
FDA action prompts BDSI to develop safety plan for patch.
BioDelivery Sciences to Consolidate Newark Operations and Bioral Amphotericin B Development at Raleigh Headquarters.
ANALYST INTERVIEW: Development in Biotech - Matthew L. Kaplan - Ladenburg Thalmann.
CEO INTERVIEW: BioDelivery Sciences International, Inc. - Mark A. Sirgo.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles